Andrea Gramegna

Assistant Professor

University of Milan

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andrea Gramegna is an Assistant Professor at the University of Milan, Italy. His research focuses on respiratory diseases, particularly bronchiectasis and cystic fibrosis, as evidenced by his recent publications on the awareness of respiratory syncytial virus vaccines among healthcare professionals and the impact of therapeutic interventions in bronchiectasis. Dr. Gramegna also explores the cardiometabolic implications in adults with cystic fibrosis, contributing to the standards of care and educational gaps within this field.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (16)

Anna Stainer

Assistant Professor

Humanitas University

ITALY

Andrea Gramegna

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Awareness of respiratory syncytial virus and other respiratory disease vaccines among healthcare professionals and their patients in Italy: Insights from a literature review and a web-based survey

Prevalence and types of treatable traits in bronchiectasis: a multicentre, cross-sectional study

Impact of long-term high-flow nasal therapy on mucus plugs in patients with bronchiectasis

Bronchiectasis and sinonasal diseases: a narrative review

Cardiometabolic risk factors in adults with cystic fibrosis undergoing elexacaftor/tezacaftor/ivacaftor therapy

The impact of cardiovascular events in bronchiectasis: a systematic review and meta-analysis

Diagnostic delay in bronchiectasis: an Italian perspective

Standards for the care of people with cystic fibrosis (CF); Planning for a longer life.

Standards of care and educational gaps in adult cystic fibrosis units: a European Respiratory Society survey

Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis

Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia

Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review

Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy.

Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience

Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes

Onset of systemic arterial hypertension after initiation of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A case series

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases

Overweight and obesity in adults with cystic fibrosis: An Italian multicenter cohort study

T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis

COVID-19 Vaccine: A Survey of Hesitancy in Patients with Celiac Disease

Collaborators (16)

Anna Stainer

Thomas Daniels

Linda Bussini

Giuseppe Mercante

gianfranco alicandro

Francesco Amati

Charlotte Addy

David Taylor-Robinson

Cristina Airoldi

fabiano di marco

Philip L Molyneaux

Alex Horsley

Gwyneth Davies

Giovanni Sotgiu

Francesco Blasi

Paolo Spagnolo

Make your next move.